Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

Enhancing the CuAAC efficiency of a Cu(I)–NHC complex in biological media by encapsulation

A. P. Prakasham*, Harshit Singh and Anja R. A. Palmans*
Department of Chemical Engineering & Chemistry and Institute for Complex Molecular Systems, Eindhoven University of Technology, P.O. Box 513, 5600 MB Eindhoven, The Netherlands. E-mail: a.palmans@tue.nl; a.p.prakasham@tue.nl

Received 3rd April 2025 , Accepted 19th May 2025

First published on 20th May 2025


Abstract

A novel [(NHC)2Cu]Br (Cu(I)–NHC) complex promotes CuAAC reactions in organic solvents, water, buffers and even complex biological media in good yields. Encapsulation of the Cu catalyst in an amphiphilic polymer enhances its performance in complex media, increases catalyst stability in the presence of glutathione and reduces cytotoxicity in HeLa cells.


Copper(I) catalysed azide–alkyne cycloaddition (CuAAC) has found widespread application in the fields of organic synthesis,1 glycoscience,2 polymers,3 and functional (bio)macromolecules.4 CuAAC is one of the best C–N bond forming reactions for the selective covalent functionalization of peptides, proteins and other biomacromolecules and has been evaluated in drug delivery,5 in bioorthogonal chemistry,6 and for various other biological applications,7,8 resulting in a chemistry Nobel prize in 2022.9–11 Despite its high appeal and convenience, CuAAC still possesses limitations such as the need for excess reducing agent (Na-ascorbate) to reduce Cu(II) to Cu(I), and for Cu(I) stabilising ligands to enhance reactions rates.12–14 CuAAC reactions work well in neat/aqueous media,15–18 but the performance of many Cu(I) complexes in complex and cellular media is poor and their toxicity is high. Despite these challenges, bio-orthogonal reactivity has been achieved for Cu(I)-based systems using triazole-based ligands for CuAAC and BTTAA ligands for NH insertion reactions.19–21

Recently, the addition of Cu(I) with N-heterocyclic carbene (NHC) ligands attached to polymeric carriers showed good biocompatibility and allowed the generation of hydroxyl radicals in in vitro and in vivo conditions.22 The NHC ligand is a perfect candidate for stabilizing the Cu(I) ion in CuAAC chemistry through its strong σ-electron donation capability and steric bulk, thereby overcoming the oxygen sensitivity of Cu(I) species to form Cu(II). While efficient [(NHC)2Cu]X type catalysts have been reported for CuAAC reactions,23 many Cu–NHC complexes require either stringent conditions (absence of air/moisture) for the synthesis of the catalysts24,25 and/or need to be activated by chemical,26 thermal,27,28 photochemical29 or mechanical means30,31 to yield 1,2,3-triazoles (Table S3, ESI). Given the high activity of Cu(I)–NHC found in CuAAC reactions in organic solvents, we here set out to develop Cu(I)–NHC complexes for CuAAC reactions in water and in complex cellular media. In this work, we report the synthesis of a new Cu(I)–NHC complex, assess its catalytic activity in a variety of media and in the presence of glutathione (GSH), and investigate its compatibility with cells.

In order to stabilize the Cu(I) state, a bulky NHC ligand was chosen having a steric 2,6-(iPr)2-C6H3 group and an anthracene pendant substitution on the N-atoms. The NHC ligand precursor (1) was synthesised by the N-alkylation of 1-(2,6-diisopropylphenyl)-imidazole with 9-(bromomethyl) anthracene (Fig. S1–S5, ESI). Subsequent reaction of (1) with CuBr in the presence of K2CO3 in acetone afforded the Cu(I)–NHC complex (2) in quantitative yield as an off-white solid (Scheme 1). Noticeably, the Cu(I) complex (2) is stable towards air and moisture. The coordination of the NHC ligand to the Cu was verified by the disappearance of the NC[H with combining low line]N resonance and the formation of the bis-NHC complex [(NHC)2Cu]Br was corroborated by the m/z peak at 899.40 that corresponds to the [M–Br]+ molecular ion of the complex [C60H60CuN4]+ through MALDI-ToF-MS, in line with structurally similar complexes (Fig. S6–S10, ESI).32 The Cu(I)–NHC complex (2) showed distinct absorption bands around 300–425 nm and weak fluorescence emissions around ca. 375–500 nm characteristics of anthracene transitions in solution as well as in the solid state (Fig. S11 and S12, ESI).


image file: d5cc01891a-s1.tif
Scheme 1 Synthesis of Cu(I)–NHC complex (2).

With the perspective of utilizing the Cu(I)–NHC in bioconjugation reactions, we here set out to test benzyl azide and phenylacetylene as model substrates in the CuAAC reaction using 0.5–2.5 mol% Cu(I)–NHC (2) to yield 1,4-substituted 1,2,3-triazole (3a) (Table S1, ESI). The reaction was initially performed in water, in which (2) did not dissolve, at 37 °C. With a catalyst loading of 1 mol%, the 1,2,3-triazole (3a) was isolated in 90% yield in 2 h, while lower loading of 0.5 mol% catalyst gave 69% yield (Table S1, entries 1–3, ESI). The Cu(I)–NHC (2), also gave high yields using a lower temperature of 20 °C, and with reduced reaction times of 1 h and 10 minutes (Table S1, entries 4–6, ESI). Mixing of the two substrates in neat conditions, without water in the presence of Cu(I)–NHC (2), quantitatively offered 3a. The absence of Cu-complex (2) in the reaction did not give 3a (Table S1, entry 9, ESI), which highlights the importance of Cu(I) catalysts in the CuAAC reactions. To ascertain uniform conditions in all catalysis reactions, we selected 1 mol% catalyst loading, T = 37 °C and 2 h reaction time as the optimum conditions.

With these conditions, we screened the activity of (2) in various solvents (Table 1). Interestingly, Cu(I)–NHC (2) performed well in various organic solvents, namely, the non-polar toluene to polar dichloromethane (DCM), tetrahydrofuran (THF), acetonitrile (ACN), and also protic tBuOH and water:DMSO mixtures (Table 1, entries 1–6). In DMF, in contrast, only 36% of 3a was isolated. Notably, the reaction proceeded in good yield in basic NaOH (0.1 M) solution (92%), and in basic buffers, PBS (90%) and Tris (88%) (Table 1, entries 9–11). Remarkably, the Cu(I)–NHC (2) effectively catalysed the cycloaddition of benzyl azide and phenylacetylene in biological cell culture media such as RPMI (Roswell Park Memorial Institute 1640) and DMEM (Dulbecco's modified Eagle's medium), affording high yields >80% (Table 1, entries 12–14).

Table 1 Solvent scope of CuAAC reaction using Cu(I)–NHC (2)a

image file: d5cc01891a-u1.tif

Entry Catalyst (mol%) Solvent Yieldb (%)
a Conditions: azide (0.25 mmol), alkyne (0.3 mmol), solvent (0.5 mL), 37 °C, 2 h.b Isolated yield.c H2O[thin space (1/6-em)]:[thin space (1/6-em)]DMSO (9[thin space (1/6-em)]:[thin space (1/6-em)]1).
1 1 tBuOH 99
2 1 THF 86
3 1 DCM 99
4 1 ACN >99
5 1 Toluene >99
6 1 H2O:DMSOc 98
7 1 DMF 36
8 1 H2O 90
9 1 NaOH (0.1 M) 92
10 1 PBS 90
11 1 Tris (0.5 M) 88
12 1 RPMI 83
13 1 DMEM 81
14 2.5 DMEM 97


We further assessed the functional group tolerance by screening a wide variety of substrates in the CuAAC reaction using Cu(I)–NHC (2). For this purpose, various substituted alkynes were reacted with benzyl azide (eqn (1)) and azidomethyl pivalate (eqn (2)) in water at 37 °C (Table 2). As was evident from the substrate scope, the electron withdrawing or donating substituents on the phenylacetylene did not show significant differences in yield (all above 87%). Also, both azides gave good yields of the respective 1,2,3-triazoles (for example, 4-Br (3b) vs. 4-OMe (3i) entries 2 and 9). Interestingly, alkynes bearing phenol (3e), carboxylic acid (3f) and aniline (3g) also gave good yields of the corresponding 1,2,3-triazole products. Moreover, both benzylic and aliphatic azide gave good to excellent isolated yields of 1,2,3-triazoles 3(a–j) and 4(a–h). Interestingly, both liquid as well as solid substrates (in the case of 3b, 3(f–g), 3j, 3(m–n), 4e, 5(a–b), and 6(a–c)) resulted in high isolated yields, which is remarkable in view of the catalyst being a solid in water.

Table 2 Substrate scope of CuAAC reaction using Cu(I)–NHC (2)a

image file: d5cc01891a-u2.tif

S. no. 3(a–j) R1 = Yieldb (%) 4(a–h) R2 = Yieldb (%)
a Azide (0.25 mmol), alkyne (0.3 mmol), Cu(I)–NHC 1 mol%, H2O (0.5 mL), 37 °C, 2 h.b Isolated yield.
1 H (3a) 90 Ph (4a) 82
2 4-Br (3b) 94 3,5-F2-C6H3 (4b) 92
3 3,5-F2 (3c) 96 3-Me-C6H4 (4c) 96
4 3,5-(CF3)2 (3d) 87 4-OMe-C6H4 (4d) 90
5 3-OH (3e) 92 3,5-(OMe)2-C6H3 (4e) 90
6 3-COOH (3f) 94 CH2Ph (4f) 94
7 4-NH2 (3g) 90 CH2OPh (4g) 96
8 3-Me (3h) 90 CH(OEt)2 (4h) 93
9 4-OMe (3i) 92    
10 3,5-(OMe)2 (3j) 88    


The scope of functional group tolerance was further assessed in Table 3. The reaction with a bis-alkyne and a highly functional 5-bromo-3-ethynylpyrazin-2-amine afforded the respective triazoles (3m; 82%) and (3n; 81%) in good yields. Cu(I)–NHC (2) promoted the cycloaddition of benzyl azide with aliphatic alkynes having a free alcohol (3o), acid (3p), NHBoc (3q), Si(iPr)3 (3r) or ether (3t) substituent in good yield. Notably, the formation of 3q, from N-Boc-propargylamine in DMEM proceeded smoothly using 2. We further extended the applicability of the Cu(I)–NHC complex (2) in the synthesis of galactose derived triazoles 5(a–b) and the anthracene derived fluorescent triazoles 6(a–c) in good yields. Reaction of phenyl azide and benzylacetylene provided the expected product in 86% yield (Table 3). Most importantly, the purification of the end products mostly involved a simple extraction using EtOAc or Et2O, followed by washing with Et2O or cold pentane, respectively, to remove traces of alkynes and to get the clean triazole products. In a few cases, a simple filtration type column was used to obtain pure triazoles.

Table 3 Substrate scope of CuAAC reaction using Cu(I)–NHC (2)a
a Azide (0.25 mmol), alkyne (0.3 mmol), Cu(I)–NHC 1 mol%, H2O (0.5 mL), 37 °C, 2 h, isolated yield.b Azide (0.625 mmol), alkyne (0.25 mmol), Cu(I)–NHC 2 mol%.c In DMEM 89% yield at 2.5 mol% catalyst.d Azide (0.125 mmol), alkyne (0.15 mmol), (2) 1 mol%.e Rection performed in 2-Me-THF.
image file: d5cc01891a-u3.tif


All liquid substrates (azide and alkyne) underwent smooth conversion to product triazoles in both water and DMEM. In contrast, the solid substrates resulted in full conversion to product only in water, but not in biological media, as seen for 9-(azidomethyl)anthracene and phenylacetylene that gave only ≈43% and 57% conversion to the product (6b) in DMEM and RPMI, respectively (Fig. S131, ESI). Remarkably, the addition of an amphiphilic heterograft polymer (8) containing randomly distributed hydrophilic and hydrophobic grafts,33–35 aided the reaction in DMEM to reach completion in 2 h at 37 °C. This is a result of the hydrophobic interior formed after collapse of the polymer in aqueous media, which increases the local concentration of the reaction components in the media through a micellar-type encapsulation (Fig. 1).


image file: d5cc01891a-f1.tif
Fig. 1 Encapsulation of Cu(I)–NHC (2) in an amphiphilic polymer (8) ensures full conversion of solid substrates in complex media.

The generality of the catalyst was tested in the multicomponent click reaction of halides in the presence of NaN3 and phenylacetylene (in situ azide formation) using the Cu(I)–NHC (2) (Table S2, ESI). As anticipated, the reaction of benzyl bromide and benzyl chloride gave triazole in 73% and 41% yields, respectively, at 37 °C in 2 h. Overnight stirring provided complete conversion to the product (Table S2, ESI).

We also tested the applicability of the Cu(I)–NHC (2) in the presence of glutathione (GSH), a biologically abundant (up to 10 mM) thiol nucleophile in cells that poison metals.36,37 Surprisingly, 2 catalysed the formation of 3a in the presence of 10 mM concentration of GSH, while it gave no product at 15 mM GSH. Remarkably, almost full activity of the Cu(I)–NHC (2) was retained when encapsulated in the amphiphilic polymer (8) when 15 mM GSH was present in the reaction mixture. Likely, the hydrophobic micro-environment prevents the GSH inhibition of Cu (Table 4). These interesting results prompted us to check the cell viability of Cu(I)–NHC (2) in the presence of HeLa cells. Using a CCK8 assay showed that Cu(I)–NHC (2) encapsulated in the polymer (8) was not toxic up to 24 h and up to an 18 μM concentration (Fig S13, ESI). In contrast, Cu(I)–NHC (2) alone was toxic starting from 3 μM, highlighting that encapsulation safeguarded the Cu(I) catalyst in the hydrophobic interior of the polymer, thus reducing Cu(I) toxicity. The analysis of the leached-out copper from the polymer using ICP-OES showed a remarkable encapsulation efficiency of 99% (Fig. S129, ESI).

Table 4 CuAAC reaction in the presence of glutathione (GSH)a

image file: d5cc01891a-u4.tif

Entry Cu(I)–NHC (2) (mol%) GSHe (equiv.) Polymer Yieldb (%)
a Conditions: azide (0.25 mmol), alkyne (0.3 mmol), Cu(I)–NHC 1 mol%, H2O (0.5 mL).b Isolated yield.c GSH added after Cu(I).d GSH added before Cu(I).e With respect to Cu(I). 2 equiv. GSH = 10 mM.f Not detected. Polymer 1.25 μmol (1[thin space (1/6-em)]:[thin space (1/6-em)]20[thin space (1/6-em)]:[thin space (1/6-em)]2000, polymer[thin space (1/6-em)]:[thin space (1/6-em)]catalyst[thin space (1/6-em)]:[thin space (1/6-em)]substrate).
1 1c 1 80
2 1d 1 81
3 1d 2 83
4 1d 3 n.d.f
5 1%d 3 Yes 75


In summary, the novel Cu(I)–NHC complex efficiently catalyzed CuAAC reactions for a wide range of azides and alkynes in organic and aqueous solvents. Importantly, high conversions are obtained in complex biological media. The use of an amphiphilic polymer accelerated the CuAAC reaction in complex media for solid substrates. Moreover, the polymer encapsulated Cu(I)–NHC performed very well even in the presence of 15 mM glutathione and was less toxic to HeLa cells. Currently, the application of Cu(I)–NHC in the synthesis and modification of complex (bio)macromolecules is underway in our laboratory.

The project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement no. 899987. We gratefully acknowledge support by The Dutch Research Council (NWO Gravitation; IPM program), the TU/e and Peter Lipman for ICP-OES analysis.

Data availability

The data supporting this article have been included as part of the ESI.

Conflicts of interest

There are no conflicts to declare.

Notes and references

  1. M. K. Jaiswal and V. K. Tiwari, Chem. Rec., 2023, 23, e202300167 CrossRef CAS PubMed.
  2. A. K. Agrahari, P. Bose, M. K. Jaiswal, S. Rajkhowa, A. S. Singh, S. Hotha, N. Mishra and V. K. Tiwari, Chem. Rev., 2021, 121, 7638–7956 CrossRef CAS PubMed.
  3. M. F. Ali and B. Ochiai, Polymers, 2024, 16, 3275 CrossRef CAS PubMed.
  4. S. Leier and F. Wuest, Pharmaceuticals, 2024, 17, 1270 CrossRef CAS PubMed.
  5. N. M. Saraiva, A. Alves, P. C. Costa and M. Correia-da-Silva, Pharmaceuticals, 2024, 17, 747 CrossRef CAS PubMed.
  6. Y. Fu, X. Zhang, L. Wu, M. Wu, T. D. James and R. Zhang, Chem. Soc. Rev., 2025, 54, 201–265 RSC.
  7. A. Y. Heble and C.-L. Chen, Biomacromolecules, 2024, 25, 1391–1407 CrossRef CAS PubMed.
  8. R. Khandelwal, M. Vasava, R. B. Abhirami and M. Karsharma, Bioorg. Med. Chem. Lett., 2024, 112, 129927 CrossRef CAS PubMed.
  9. L. Taiariol, C. Chaix, C. Farre and E. Moreau, Chem. Rev., 2022, 122, 340–384 CrossRef CAS PubMed.
  10. C. W. Tornøe, C. Christensen and M. Meldal, J. Org. Chem., 2002, 67, 3057–3064 CrossRef PubMed.
  11. V. V. Rostovtsev, L. G. Green, V. V. Fokin and K. B. Sharpless, Angew. Chem., Int. Ed., 2002, 41, 2596–2599 CrossRef CAS PubMed.
  12. A. Szkółka, P. W. Szafrański, P. Kasza, P. Talik, M. Krośniak, M. Cegła and P. Zajdel, Org. Process Res. Dev., 2024, 28, 3257–3266 CrossRef.
  13. M. Yang, A. S. Jalloh, W. Wei, J. Zhao, P. Wu and P. R. Chen, Nat. Commun., 2014, 5, 4981 CrossRef CAS PubMed.
  14. G. C. Rudolf and S. A. Sieber, ChemBioChem, 2013, 14, 2447–2455 CrossRef CAS PubMed.
  15. N. Aflak, F.-E. Essebbar, L. Bahsis, H. Ben El Ayouchia, H. Anane, M. Julve and S.-E. Stiriba, RSC Sustainable, 2024, 2, 2949–2958 RSC.
  16. L. Bahsis, E.-H. Ablouh, Z. Hanani, H. Sehaqui, M. El Achaby, M. Julve and S.-E. Stiriba, Carbohydr. Polym., 2024, 324, 121501 CrossRef CAS PubMed.
  17. S. Díez-González, A. Correa, L. Cavallo and S. P. Nolan, Chem. – Eur. J., 2006, 12, 7558–7564 CrossRef PubMed.
  18. S. Díez-González, E. C. Escudero-Adán, J. Benet-Buchholz, E. D. Stevens, A. M. Z. Slawin and S. P. Nolan, Dalton Trans., 2010, 39, 7595 RSC.
  19. S. Gutiérrez, M. Tomás-Gamasa and J. L. Mascareñas, Angew. Chem., Int. Ed., 2021, 60, 22017–22025 CrossRef PubMed.
  20. J. Miguel-Ávila, M. Tomás-Gamasa, A. Olmos, P. J. Pérez and J. L. Mascareñas, Chem. Sci., 2018, 9, 1947–1952 RSC.
  21. Y. Bai, X. Feng, H. Xing, Y. Xu, B. K. Kim, N. Baig, T. Zhou, A. A. Gewirth, Y. Lu, E. Oldfield and S. C. Zimmerman, J. Am. Chem. Soc., 2016, 138, 11077–11080 CrossRef CAS PubMed.
  22. D. Zheng, J. Tao, L. Jiang, X. Zhang, H. He, X. Shen, Y. Sang, Y. Liu, Z. Yang and Z. Nie, J. Am. Chem. Soc., 2025, 147, 998–1007 CrossRef PubMed.
  23. S. Díez-González and S. P. Nolan, Angew. Chem., Int. Ed., 2008, 47, 8881–8884 CrossRef PubMed.
  24. A. Yagmurlu, N. Buğday, Ş. Yaşar, H. Boulebd, L. Mansour, W. S. Koko, N. Hamdi and S. Yaşar, Appl. Organomet. Chem., 2024, 38, e7545 CrossRef CAS.
  25. M. González-Lainez, M. Gallegos, J. Munarriz, R. Azpiroz, V. Passarelli, M. V. Jiménez and J. J. Pérez-Torrente, Organometallics, 2022, 41, 2154–2169 CrossRef PubMed.
  26. H. Kim, H. Kim, K. Kim and E. Lee, Inorg. Chem., 2021, 60, 18687–18697 CrossRef CAS PubMed.
  27. M. Riethmann, S. A. Föhrenbacher, H. Keiling, N. V. Ignat’ev, M. Finze and U. Radius, Inorg. Chem., 2024, 63, 8351–8365 CrossRef CAS PubMed.
  28. S. Díez-González, E. D. Stevens and S. P. Nolan, Chem. Commun., 2008, 4747 RSC.
  29. A. Islam Sk, A. Ghosh, K. Kundu, I. Murugan and P. K. Kundu, Chem. – Eur. J., 2024, 30, e202402381 CrossRef CAS PubMed.
  30. K. S. Shinde, P. Michael, D. Fuhrmann and W. H. Binder, Macromol. Chem. Phys., 2023, 224, 2200207 CrossRef CAS.
  31. M. Biewend, S. Neumann, P. Michael and W. H. Binder, Polym. Chem., 2019, 10, 1078–1088 RSC.
  32. O. Santoro, F. Lazreg, D. B. Cordes, A. M. Z. Slawin and C. S. J. Cazin, Dalton Trans., 2016, 45, 4970–4973 RSC.
  33. M. Artar, E. R. J. Souren, T. Terashima, E. W. Meijer and A. R. A. Palmans, ACS Macro Lett., 2015, 4, 1099–1103 CrossRef CAS PubMed.
  34. A. Sathyan, S. Croke, A. M. Pérez-López, B. F. M. de Waal, A. Unciti-Broceta and A. R. A. Palmans, Mol. Syst. Des. Eng., 2022, 7, 1736–1748 RSC.
  35. A. Sathyan, T. Loman, L. Deng and A. R. A. Palmans, Nanoscale, 2023, 15, 12710–12717 RSC.
  36. Y. M. Wilson, M. Dürrenberger, E. S. Nogueira and T. R. Ward, J. Am. Chem. Soc., 2014, 136, 8928–8932 CrossRef CAS PubMed.
  37. H. Zhao, Z. Liu, Y. Wei, L. Zhang, Z. Wang, J. Ren and X. Qu, ACS Nano, 2022, 16, 20353–20363 CrossRef CAS PubMed.

Footnote

Electronic supplementary information (ESI) available: Experimental procedures, characterization and spectroscopic data; 1H NMR, 13C{1H} NMR, and MALDI-ToF-MS spectra, absorption and emission spectra of the precarbene ligand (1) and Cu(I)-NHC complex (2), catalysis procedures, and 1H NMR, 13C{1H} NMR and MALDI for the catalysis products are available in the electronic supplementary information. See DOI: https://doi.org/10.1039/d5cc01891a

This journal is © The Royal Society of Chemistry 2025
Click here to see how this site uses Cookies. View our privacy policy here.